Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

1.47
+0.02001.38%
Post-market: 1.480.0100+0.68%19:17 EDT
Volume:84.59K
Turnover:126.11K
Market Cap:7.75M
PE:-0.48
High:1.53
Open:1.45
Low:1.45
Close:1.45
52wk High:8.34
52wk Low:1.31
Shares:5.27M
Float Shares:4.17M
Volume Ratio:0.18
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0454
EPS(LYR):-5.3153
ROE:-128.11%
ROA:-55.92%
PB:0.95
PE(LYR):-0.28

Loading ...

Acurx prices $2.5 million registered direct offering at $3.03 per share

Reuters
·
Apr 16

Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Apr 16

New to The Street announce re-signing of Acurx Pharmaceuticals

TIPRANKS
·
Apr 07

Acurx wins Korean patent for DNA Polymerase IIIC inhibitor antibiotics

Reuters
·
Mar 30

Top Premarket Gainers

MT Newswires Live
·
Mar 24

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Mar 14

Acurx Pharmaceuticals (ACXP) Gets a Buy from Alliance Global Partners

TIPRANKS
·
Mar 14

Acurx price target lowered to $10 from $20 at Alliance Global

TIPRANKS
·
Mar 14

Acurx Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 13

Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend

Reuters
·
Mar 13

Acurx Pharmaceuticals Q4 EPS $(0.73) Beats $(1.65) Estimate

Benzinga Earnings
·
Mar 13

Acurx Pharmaceuticals Q4 EPS USD -0.73

THOMSON REUTERS
·
Mar 13

Press Release: Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

Dow Jones
·
Mar 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 13

Top Premarket Decliners

MT Newswires Live
·
Mar 12

Why Is Acurx Pharmaceuticals Stock Up Over 105% Today?

Benzinga_recent_news
·
Mar 12

Acurx Pharmaceuticals Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
Mar 11

Acurx Pharmaceuticals: Effective April 1, 2026, CEO & Executive Chairman Salaries Reduced to $495,000, CFO Salary Reduced to $360,000 - SEC Filing

THOMSON REUTERS
·
Mar 09

Acurx Pharmaceuticals Inc - Approves Voluntary Reductions to Executive Base Salaries - SEC Filing

THOMSON REUTERS
·
Mar 09

Acurx Pharmaceuticals Inc - Trial Start-up for Rcdi to Begin This Month; First Patient Expected Q4 2026

THOMSON REUTERS
·
Mar 09